COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,870 Articles (22,568 medRxiv, 8,302 bioRxiv)

Most recent first Previous |  Page 2519: Articles 25181-25190  | Next

Modeling the effect of COVID-19 disease on the cardiac function: a computational study
Regazzoni, F., Vergara, C., Dede', L., Zunino, P., Guglielmo, M., Scrofani, R., Fusini, L., Cogliati, C., Pontone, G., Quarteroni, A.
10.1101/2020.06.23.166421 — Posted: 2020-06-23
Oral epithelial expression of angiotensin converting enzyme-2: Implications for COVID-19 diagnosis and prognosis.
Srinivasan, M., Zunt, S. L., Goldblatt, L. I.
10.1101/2020.06.22.165035 — Posted: 2020-06-23
Accommodating individual travel history, global mobility, and unsampled diversity in phylogeography: a SARS-CoV-2 case study.
Lemey, P., Hong, S., Hill, V., Baele, G., Poletto, C., Colizza, V., O'Toole, A., McCrone, J. T., Andersen, K. G., Worobey, M., Nelson, M. I., Rambaut, A., Suchard, M. A.
10.1101/2020.06.22.165464 — Posted: 2020-06-23
Green tea and Spirulina extracts inhibit SARS, MERS, and SARS-2 spike pseudotyped virus entry in vitro
Joseph, J., Thankamani, K., Ajay, A., Das, V. R. A., Raj, V. S.
10.1101/2020.06.20.162701 — Posted: 2020-06-23
Systemic analysis of putative SARS-CoV-2 entry and processing genes in cardiovascular tissues identifies a positive correlation of BSG with age in endothelial cells
Ahmetaj-Shala, B., Vaja, R.-K., Atanur, S. S., George, P. M., Kirkby, N. S., Mitchell, J. A.
10.1101/2020.06.23.165324 — Posted: 2020-06-23
Genetic Diversity and Genomic Epidemiology of SARS-COV-2 in Morocco
Badaoui, B., Sadki, K., Talbi, C., Tazi, L., Salah, D.
10.1101/2020.06.23.165902 — Posted: 2020-06-23
ViralLink: An integrated workflow to investigate the effect of SARS-CoV-2 on intracellular signalling and regulatory pathways
Treveil, A., Bohar, B., Sudhakar, P., Gul, L., Csabai, L., Olbei, M., Poletti, M., Madgwick, M., Andrighetti, T., Hautefort, I., Modos, D., Korcsmaros, T.
10.1101/2020.06.23.167254 — Posted: 2020-06-23
Biochemical evidence of furin specificity and potential for phospho-regulation at Spike protein S1/S2 cleavage site in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV
Örd, M., Faustova, I., Loog, M.
10.1101/2020.06.23.166900 — Posted: 2020-06-23
SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography
Klein, S., Cortese, M., Winter, S. L., Wachsmuth-Melm, M., Neufeldt, C. J., Cerikan, B., Stanifer, M. L., Boulant, S., Bartenschlager, R., Chlanda, P.
10.1101/2020.06.23.167064 — Posted: 2020-06-23
RAAS blockade, kidney disease, and expression of ACE2, the entry receptor for SARS-CoV-2, in kidney epithelial and endothelial cells
Subramanian, A., Vernon, K., Slyper, M., Waldman, J., Luecken, M. D., Gosik, K., Dubinsky, D., Cuoco, M., Keller, K., Purnell, J., Nguyen, L., Dionne, D., Rozenblatt-Rosen, O., Weins, A., Human Cell Atlas Lung Biological Network, , Regev, A., Greka, A.
10.1101/2020.06.23.167098 — Posted: 2020-06-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).